Global Brachytherapy Market Overview
Brachytherapy is a type of radiotherapy in which wrapped radiation source is placed inside or next to the area demanding treatment. Brachytherapy devices are mainly utilized for effectively treating cervical, breast, prostate, and skin cancer and as well as the tumors in several other body sites. Brachytherapy is a type of radiotherapy where a fixed radiation source is put inside or close to the space requiring therapy. Brachytherapy is ordinarily utilized as a powerful therapy for cervical, prostate, bosom, esophageal and skin malignancy and can likewise be utilized to treat tumors in numerous other body locales. Therapy results have exhibited that the disease fix paces of brachytherapy are either tantamount to a medical procedure or outer bar radiotherapy (EBRT) or are further developed when utilized in blend with these methods. Brachytherapy can be utilized alone or in blend with different treatments like a medical procedure, EBRT and chemotherapy. Brachytherapy diverges from unlocked source radiotherapy, in which a helpful radionuclide (radioisotope) is infused into the body to artificially restrict to the tissue requiring obliteration. It additionally differentiations to External Beam Radiation Therapy (EBRT), in which high-energy x-beams (or periodically gamma-beams from a radioisotope like cobalt-60) are aimed at the tumor from outside the body. Brachytherapy rather includes the exact situation of short-range radiation-sources (radioisotopes, iodine-125 or cesium-131 for example) straightforwardly at the site of the dangerous tumor. These are encased in a defensive case or wire, which permits the ionizing radiation to disappear to treat and kill encompassing tissue however keeps the charge of radioisotope from moving or dissolving in body liquids. The case might be taken out later, or (with certain radioisotopes) it could be permitted to stay in place. The global Brachytherapy market accounted for US$ 688.5 million in 2020 and is estimated to be US$ 1415.8 million by 2030 and is anticipated to register a CAGR of 7.50%.
Global Brachytherapy Market Dynamics
Rising number of cancer patients
As per to the World Health Organization (WHO), cancer is one of the foremost causes of morbidity and mortality worldwide. In low- and middle-income countries, about 70% of cancer-related deaths occur. The American Cancer Society reported that these countries have a growing number of cancer patients and they lack radiation therapy access. This factor is projected to provide innovative opportunities to the existing market players in these regions.
Technological advancements
R&D initiatives adopted by the key players and technological developments in the field of oncology treatment are some of the major growth boosting growth of the target market. Moreover, the key players are opting for acquisitions of smaller players to expand their regional presence. For example, in U.S., iCAD markets the eBx system through its subsidiary Xoft. iCAD quantified with over 12,000 installation opportunities for tomosynthesis systems in U.S., there is a significant opportunity for CAD in future and density assessment solutions for tomosynthesis.
However, higher reimbursement in field of radiation therapy and presence of substitutes in the market can restrain the growth of the global market over the forecast period. Additionally, side effects of the treatment will also limit the target market in the coming years.
Global Brachytherapy Market Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The global brachytherapy market is segmented based on technique, application, and region.
On the basis of technique, the global brachytherapy market is segmented into high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, pulse dose rate (PDR) brachytherapy, and image guided brachytherapy (IGBT). On the basis of application, the target market is classified into prostate cancer, breast cancer, gynecological cancer, cervical cancer, skin cancer, and others.
Regional Insights:
On region the global brachytherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the highest market share in 2017. Brachytherapy is extensively used in North America owing to benefits it offers over traditional methods as it is comparatively efficient and safer cancer treatment. As per American Cancer Society, in 2018, above 2 million new cancer cases will be analyzed in U.S. Asia Pacific Brachytherapy market forecast largest CAGR rate in the coming years from 2018 to 2025. The region estimates for about 60% of world population and half the global burden of cancer. The incidence of cancer is growing pertaining to unhealthy lifestyle. Moreover, partial access to technologically advanced cancer treatments provides a huge scope for the market players.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2019 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Technique - High Dose Rate (HDR) Brachytherapy, Low Dose Rate (LDR) Brachytherapy, Pulse Dose Rate (PDR) Brachytherapy, and Image Guided Brachytherapy (IGBT) By Application - Prostate Cancer, Breast Cancer, Gynecological Cancer, Cervical Cancer, Skin Cancer, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest application trends and opportunities in each of the sub-segments from 2019 to 2026. For the purpose of this study, has segmented the global brachytherapy market report based on technique, application, and region.
Brachytherapy Market, By Technique:
- High Dose Rate (HDR) Brachytherapy
- Low Dose Rate (LDR) Brachytherapy
- Pulse Dose Rate (PDR) Brachytherapy
- Image Guided Brachytherapy (IGBT)
Brachytherapy Market, By Application:
- Prostate Cancer
- Breast Cancer
- Gynecological Cancer
- Cervical Cancer
- Skin Cancer
- Others
Brachytherapy Market, By Region:
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
Global Brachytherapy Market Key Players
The key players operating the global brachytherapy market includes Modus Medical Devices Inc., Varian Medical Systems, Inc., Eckert & Ziegler BEBIG GmbH, R. Bard, Inc., Argon Medical Devices, Inc., Elekta AB (publ), IsoRay Medical, Inc., IsoAid, L.L.C., Theragenics Corporation, and Medical Instruments Co., Inc. Prominent players have been adopting several strategies to increase and strengthen their occurrence worldwide. As cancer care totally depends on R&D and innovations, the market is likely to register significant growth over the forecast period. Some of the companies opt for partnerships and mergers to capture the untapped markets.
Global Brachytherapy Market Company Profile
- Modus Medical Devices Inc.
- Company Overview
- Product Technique Portfolio
- Key Highlights
- Financial PerRaw Materialance
- Business Strategies
- Varian Medical Systems, Inc.
- Eckert & Ziegler BEBIG GmbH
- R. Bard, Inc.
- Argon Medical Devices, Inc.
- Elekta AB (publ)
- IsoRay Medical, Inc.
- IsoAid, L.L.C.
- Theragenics Corporation
- Medical Instruments Co., Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Brachytherapy Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Brachytherapy Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technique
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Brachytherapy Market, By Technique, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Segment Trends
- High Dose Rate (HDR) Brachytherapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Low Dose Rate (LDR) Brachytherapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Pulse Dose Rate (PDR) Brachytherapy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Image Guided Brachytherapy (IGBT)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Overview
- Global Brachytherapy Market, By Application, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Segment Trends
- Prostate Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Breast Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Gynecological Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Cervical Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Skin Cancer
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2026
- Overview
- Global Brachytherapy Market, By Region, 2018 – 2026, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 – 2026
- Y-o-Y Growth Analysis (%), 2018 – 2026
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Technique, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Technique, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Technique, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Technique, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Technique, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2026
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2026
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Modus Medical Devices Inc.
- Company Overview
- Technique Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Varian Medical Systems, Inc.
- Eckert & Ziegler BEBIG GmbH
- R. Bard, Inc.
- Argon Medical Devices, Inc.
- Elekta AB (publ)
- IsoRay Medical, Inc.
- IsoAid, L.L.C.
- Theragenics Corporation
- Medical Instruments Co., Inc.
- Modus Medical Devices Inc.
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global brachytherapy market is segmented based on technique, application, and region.
The rising number of cancer patients is driving the growth of the global brachytherapy market.
North America accounted for the highest market share in 2017. Brachytherapy is extensively used in North America owing to the benefits it offers over traditional methods as it is comparatively efficient and safer cancer treatment.
Prominent players have been adopting several strategies to increase and strengthen their occurrence worldwide. As cancer care totally depends on R&D and innovations, the market is likely to register significant growth over the forecast period. Some of the companies opt for partnerships and mergers to capture the untapped markets.